Skip to main content
ZELIRA THERAPEUTICS LIMITED logo

ZELIRA THERAPEUTICS LIMITED — Investor Relations & Filings

Ticker · ZLD ISIN · AU000000ZLD1 ASX Manufacturing
Filings indexed 974 across all filing types
Latest filing 2026-04-28 Interim / Quarterly Rep…
Country AU Australia
Listing ASX ZLD

About ZELIRA THERAPEUTICS LIMITED

https://zeliratx.com/

Zelira Therapeutics Limited is a biopharmaceutical company focused on the research, development, and commercialization of clinically validated cannabinoid-based medicines. The company utilizes a data-driven approach to develop therapeutic products targeting conditions such as insomnia, chronic pain, and autism. Its portfolio includes Zenivol, a clinically validated treatment for insomnia, and the HOPE range of products designed for patients with autism. Zelira emphasizes a clinical trial-led strategy to establish the safety and efficacy of its formulations, aiming to provide healthcare professionals and patients with evidence-based cannabinoid treatments. The company also explores dermatological applications and maintains a pipeline of proprietary formulations undergoing rigorous scientific evaluation to address unmet medical needs in global markets.

Recent filings

Filing Released Lang Actions
Quarterly Activities/Appendix 4C Cash Flow Report 10 pages 688.0KB
Interim / Quarterly Report Classification · 85% confidence The document is an ASX Announcement presenting Zelira’s Quarterly Activities Report and Appendix 4C cash flow statement for Q3 FY2026. It includes substantive financial data (quarterly cash flows, operational highlights, strategic outlook) rather than merely announcing publication of a separate report. Under the filing definitions, this constitutes an Interim/Quarterly Report covering a period shorter than a full fiscal year with actual financial statements and analysis. Q3 2026
2026-04-28 English
Director Loan 4 pages 1.9MB
Regulatory Filings
2026-03-09 English
Quarterly Activities/Appendix 4C Cash Flow Report 9 pages 665.7KB
Regulatory Filings
2026-01-28 English
Transformative US$33M Fundraising into Zeliras HOPE 1 SPV 6 pages 2.1MB
Regulatory Filings
2026-01-15 English
Notification regarding unquoted securities - ZLD 5 pages 16.6KB
Regulatory Filings
2025-12-03 English
Change of Director's Interest Notice x2 4 pages 320.7KB
Regulatory Filings
2025-12-03 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.